Cite
Stakeholder acceptability of adolescent participation in clinical trials for biomedical HIV prevention products: considerations from Tanzania and India.
MLA
Pack, Allison P., et al. “Stakeholder Acceptability of Adolescent Participation in Clinical Trials for Biomedical HIV Prevention Products: Considerations from Tanzania and India.” AIDS Care, vol. 31, no. 7, July 2019, pp. 857–63. EBSCOhost, https://doi.org/10.1080/09540121.2018.1563285.
APA
Pack, A. P., Sastry, J., Tolley, E. E., Kaaya, S., Headley, J., Kaale, A., & Baumgartner, J. N. (2019). Stakeholder acceptability of adolescent participation in clinical trials for biomedical HIV prevention products: considerations from Tanzania and India. AIDS Care, 31(7), 857–863. https://doi.org/10.1080/09540121.2018.1563285
Chicago
Pack, Allison P, Jayagowri Sastry, Elizabeth E Tolley, Sylvia Kaaya, Jennifer Headley, Anna Kaale, and Joy Noel Baumgartner. 2019. “Stakeholder Acceptability of Adolescent Participation in Clinical Trials for Biomedical HIV Prevention Products: Considerations from Tanzania and India.” AIDS Care 31 (7): 857–63. doi:10.1080/09540121.2018.1563285.